Cargando…

A Novel 10-Gene Signature Predicts Poor Prognosis in Low Grade Glioma

AIM: Low grade glioma (LGG) is a lethal brain cancer with relatively poor prognosis in young adults. Thus, this study was performed to develop novel molecular biomarkers to effectively predict the prognosis of LGG patients and finally guide treatment decisions. METHODS: survival-related genes were d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wentao, Zou, Jiaxuan, Ren, Rijun, Liu, Jingping, Zhang, Gentang, Wang, Maokai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7876581/ https://www.ncbi.nlm.nih.gov/pubmed/33550903 http://dx.doi.org/10.1177/1533033821992084

Ejemplares similares

Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma
por: Li, Yong, et al.
Publicado: (2020)

A Novel Inflammatory lncRNAs Prognostic Signature for Predicting the Prognosis of Low-Grade Glioma Patients
por: Xiang, Zijin, et al.
Publicado: (2021)

Metabolic Signature-Based Subtypes May Pave Novel Ways for Low-Grade Glioma Prognosis and Therapy
por: Li, Ganglei, et al.
Publicado: (2021)

A Novel-Defined Necroptosis-Related miRNA Signature for Forecasting the Prognosis of Low-Grade Glioma
por: Lu, Zhuangzhuang, et al.
Publicado: (2022)

Deletion and low expression of NFKBIA are associated with poor prognosis in lower-grade glioma patients
por: Kinker, Gabriela Sarti, et al.
Publicado: (2016)

Elevated CD44 expression predicts poor prognosis in patients with low-grade glioma
por: Dong, Qiang, et al.
Publicado: (2019)

Microglia-Based Gene Expression Signature Highly Associated with Prognosis in Low-Grade Glioma
por: Schaafsma, Evelien, et al.
Publicado: (2022)

A Novel TNFSF-Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower-Grade Glioma
por: Tao, Rui, et al.
Publicado: (2022)

Identification of an energy metabolism-related six-gene signature for distinguishing and forecasting the prognosis of low-grade gliomas
por: Liu, Guoli, et al.
Publicado: (2023)

IGFBPs were associated with stemness, inflammation, extracellular matrix remodeling and poor prognosis of low-grade glioma
por: Liu, Zhihui, et al.
Publicado: (2022)

Identification and Validation of a Seizure-Free-Related Gene Signature for Predicting Poor Prognosis in Lower-Grade Gliomas
por: Li, Jinxing, et al.
Publicado: (2021)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

High-expression of Galactosidase alpha is correlated with poor prognosis and immune infiltration in low-grade glioma
por: Zhang, Yi, et al.
Publicado: (2023)

Identification and verification of the ferroptosis- and pyroptosis-associated prognostic signature for low-grade glioma
por: Wang, Jie, et al.
Publicado: (2022)

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma
por: Xiao, Youchao, et al.
Publicado: (2020)

Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas
por: Tan, Shichuan, et al.
Publicado: (2022)

Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022)

The CD2–CD58 axis: A novel marker predicting poor prognosis in patients with low‐grade gliomas and potential therapeutic approaches
por: Wu, Mingwei, et al.
Publicado: (2023)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

Establishment of an Endocytosis-Related Prognostic Signature for Patients With Low-Grade Glioma
por: Wang, Dawei, et al.
Publicado: (2021)

Autophagy related DNA methylation signature predict clinical prognosis and immune microenvironment in low-grade glioma
por: Qiao, Qiujiang, et al.
Publicado: (2022)

Ferroptosis in Low-Grade Glioma: A New Marker for Diagnosis and Prognosis
por: Liu, Yan, et al.
Publicado: (2020)

Hypomethylation of CNTFRα is associated with proliferation and poor prognosis in lower grade gliomas
por: Fan, Kun, et al.
Publicado: (2017)

High Expression of PLAGL2 is Associated With Poor Prognosis in High-Grade Glioma
por: Wang, Gang, et al.
Publicado: (2022)

MAGOH is correlated with poor prognosis and is essential for cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma
por: Lu, Jiajie, et al.
Publicado: (2021)

Elevated RECQL1 expression predicts poor prognosis and associates with tumor immune infiltration in low-grade glioma
por: Wang, Guiyuan, et al.
Publicado: (2022)

The Tropomyosin Family as Novel Biomarkers in Relation to Poor Prognosis in Glioma
por: Huang, Ke, et al.
Publicado: (2022)

Development and Verification of Glutamatergic Synapse-Associated Prognosis Signature for Lower-Grade Gliomas
por: Ye, Liguo, et al.
Publicado: (2021)

A GLO10 score for the prediction of prognosis in high grade gliomas
por: Chen, Feng, et al.
Publicado: (2017)

A Bioinformatics-Based Analysis of an Anoikis-Related Gene Signature Predicts the Prognosis of Patients with Low-Grade Gliomas
por: Zhao, Songyun, et al.
Publicado: (2022)

Prognosis and immune features of pyroptosis-related RNA patterns in low-grade glioma
por: Liu, Hanzhang, et al.
Publicado: (2022)

RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas
por: Zhao, Xu, et al.
Publicado: (2022)

Decreased FOXD3 Expression Is Associated with Poor Prognosis in Patients with High-Grade Gliomas
por: Du, Wei, et al.
Publicado: (2015)

MGME1 associates with poor prognosis and is vital for cell proliferation in lower-grade glioma
por: Xiao, Feng, et al.
Publicado: (2023)

A novel cuproptosis-related gene signature to predict prognosis in Glioma
por: Zhang, Mengyang, et al.
Publicado: (2023)

A novel tailored immune gene pairs signature for overall survival prediction in lower-grade gliomas
por: Pan, Xuyan, et al.
Publicado: (2021)

Identification, and Experimental and Bioinformatics Validation of an Immune-Related Prognosis Gene Signature for Low-Grade Glioma Based on mRNAsi
por: Wang, Yuan, et al.
Publicado: (2023)

A Metabolic Plasticity-Based Signature for Molecular Classification and Prognosis of Lower-Grade Glioma
por: Yang, Ming-Chun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7kc2o8ee17c64qdu11pdkdq26u